CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 31 filers reported holding CASI PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $12,000 | -33.3% | 15,090 | 0.0% | 0.01% | -16.7% |
Q3 2021 | $18,000 | -21.7% | 15,090 | 0.0% | 0.01% | -14.3% |
Q2 2021 | $23,000 | 0.0% | 15,090 | 0.0% | 0.01% | -36.4% |
Q3 2020 | $23,000 | -39.5% | 15,090 | 0.0% | 0.01% | -50.0% |
Q2 2020 | $38,000 | -45.7% | 15,090 | 0.0% | 0.02% | -15.4% |
Q3 2018 | $70,000 | -43.5% | 15,090 | 0.0% | 0.03% | -48.0% |
Q2 2018 | $124,000 | +359.3% | 15,090 | 0.0% | 0.05% | +284.6% |
Q3 2017 | $27,000 | +68.8% | 15,090 | 0.0% | 0.01% | +62.5% |
Q2 2017 | $16,000 | -23.8% | 15,090 | 0.0% | 0.01% | -11.1% |
Q1 2017 | $21,000 | +23.5% | 15,090 | 0.0% | 0.01% | +28.6% |
Q3 2016 | $17,000 | -5.6% | 15,090 | 0.0% | 0.01% | -12.5% |
Q2 2016 | $18,000 | +12.5% | 15,090 | 0.0% | 0.01% | +33.3% |
Q1 2016 | $16,000 | 0.0% | 15,090 | 0.0% | 0.01% | -14.3% |
Q3 2015 | $16,000 | -40.7% | 15,090 | 0.0% | 0.01% | -12.5% |
Q2 2015 | $27,000 | 0.0% | 15,090 | 0.0% | 0.01% | +33.3% |
Q3 2014 | $27,000 | – | 15,090 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
IDG-Accel China Growth Fund III Associates L.P. | 7,973,536 | $12,359,000 | 22.48% |
Consonance Capital Management LP | 10,321,956 | $15,999,000 | 1.92% |
Wellington Shields & Co., LLC | 1,832,769 | $2,841,000 | 0.94% |
Wellington Shields Capital Management, LLC | 2,258,264 | $3,500,000 | 0.42% |
Ghost Tree Capital, LLC | 650,000 | $1,008,000 | 0.28% |
Ikarian Capital, LLC | 1,268,154 | $1,966,000 | 0.16% |
Tibra Equities Europe Ltd | 216,300 | $335,000 | 0.10% |
1492 Capital Management LLC | 79,743 | $124,000 | 0.06% |
FEDERATED HERMES, INC. | 10,150,000 | $15,733,000 | 0.03% |
Sterneck Capital Management, LLC | 40,000 | $47,000 | 0.03% |